AP-SA02

Armata Announces Phase 2a Success for S. aureus Phage Therapy

Los Angeles, CA – October 22, 2025 — Armata Pharmaceuticals, Inc., a biotechnology company advancing bacteriophage-based therapeutics, announced positive...

By cGxPwire Editor
October 22, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

AP-SA02

Armata Announces Phase 2a Success for S. aureus Phage Therapy